An International Perspective on Advancing Technologies and Strategies for Managing Dual-Use Risks: Report of a Workshop (2005)
Chapter: Appendix A: Workshop Agenda
Appendix A
Workshop Agenda
Advancing Technologies: Surveying the Global Capacity for Research, Development, and Application
Policy and Global Affairs Division/National Research Council
The Board on Global Health/ Institute of Medicine
The National Academies
September 21-September 22, 2004
Instituto Nacional de Salud Publica
Cuernavaca, Mexico
Committee on Advances in Technology and the Prevention of Their Application to Next Generation
Bioterrorism and Biological Warfare Threats
AGENDA
Tuesday, September 21, 2004
|
8:30 |
Coffee |
|
9:00 |
Welcome and Opening Remarks/Goals of the Meeting |
|
|
Stanley Lemon, M.D., Committee Co-Chair/The University of Texas Branch at Galveston David Relman, M.D., Committee Co-chair/ Stanford University Mauricio Hernandez, M.D., Instituto Nacional de Salud Publica, Cuernavaca, Mexico |
Session I: Drivers of Global Technological Development
|
|
Moderator: David Relman, M.D., Committee Co-chair/ Stanford University |
|
9:45 |
The Economic Opportunities of the Global Workforce and Marketplace (comparative advantage; market capture; select workforce) Terence Taylor, IISS-US |
|
10:05 |
Q&A/Discussion |
|
10:20 |
Technological Approaches to Overcoming Health and Development Challenges David Banta, M.D., WHO and World Bank Consultant |
|
10:40 |
Discussion |
|
11:00-11:15 |
BREAK |
Session II: The Global Landscape of Technology/Efforts to Mitigate Risks for Misapplication
|
|
Moderator: Stanley Lemon, M.D., Committee Co-Chair/ The University of Texas Branch at Galveston |
|
11:15-11:35 |
Global Cooperation in the Development of Biotechnology Decio Ripandelli, International Centre for Genetic Engineering and Biotechnology |
|
11:35-12:00 |
Discussion |
|
12:00 |
LUNCH |
|
1:00-2:15 |
AGRICULTURE/ LIVESTOCK BREEDING/BIOPhARMING |
|
1:00-1:45 |
Panel Discussion: |
|
|
Charles Arntzen, Ph.D., Arizona State University, and Miguel Gomez Lim, Ph.D., CINVESTAV-Irapuato, Mexico Luis Herrera-Estrella, Ph.D., Center for Research and Advanced Studies, National Polytechnic Institute, Irapuato, Mexico |
|
1:45-2:15 |
Q&A/Discussion |
|
2:15-3:50 |
VACCINES, PHARMACEUTICAL DEVELOPMENT AND HUMAN GENOMICS Panel Discussion: Rosiceli Barreto Gonçalves Baetas, D.Sc., Biomanguinhos, Fiocruz, Brazil Jacques Ravel, Ph.D., The Institute for Genomic Research Patrick Tan Boon Ooi, Ph.D., Genome Institute of Singapore Abdallah Daar, M.D., Center for Bioethics, University of Toronto Gerardo Jimenez-Sanchez, National Institute of Genomic Medicine, Mexico |
|
3:50-4:05 |
BREAK |
|
4:05-5:05 |
Q&A/Discussion |
Session III: Discussion
|
Moderators: |
Nancy Connell, Ph.D., UMDNJ/NJ Medical School Christopher Chyba, Ph.D., Stanford University and SETI Institute |
|
5:05-6:00 |
—Open Discussion—- |
|
6:00 |
Adjournment of Day 1 |
Wednesday, September 22, 2004
|
8:30 |
Coffee |
|
9:00 |
Opening Remarks / Summary of Day 1 Stanley Lemon, M.D. |
Session IV: Safeguarding the Benefits of Technology—Addressing the “Dual-Use” Dilemma
|
Moderator: |
Christopher Chyba, Ph.D., Stanford University and SETI Institute |
|
9:00-9:30 |
An Update on the BWC Intercessional Meetings, Ambassador Tibor Toth |
|
9:30-10:00 |
Q&A/Discussion |
|
10:00-11:45 |
Non-proliferation and Other Mitigation Strategies Discussion Panel: |
|
10:00-10:15 |
Amy Sands, Ph.D., Monterey Institute of International Studies |
|
10:15-10:30 |
Robert Mathews, D.Sc., Australian Defence Science and Technology Organisation |
|
10:30-10:45 |
Jerome Amir Singh, Ph.D., Nelson R. Mandela School of Medicine, Durban, South Africa |
|
10:45-11:00 |
Peter Herby, International Committee of the Red Cross, Geneva, Switzerland |
|
11:00-11:15 |
Terence Taylor, IISS-US |
|
11:15 |
BREAK |
|
11:30-12:30 |
OPEN DISCUSSION |
|
12:30-1:30 |
LUNCH |
Session V: Emerging and Converging Technologies
|
Moderator: |
David Relman, M.D., Committee Co-chair/ Stanford University |
|
1:30-3:00 |
NANOTECHNOLOGY/BIOTECHNOLOGY/CONVERGING TECHNOLOGIES |
|
9:30-10:45 |
Lead Discussants: Nadrian Seeman, Ph.D., New York University Michael Morgan, Ph.D., The Wellcome Trust |
|
3:00-3:30 |
Q&A/Discussion |
|
3:30 |
BREAK |
|
3:45-4:20 |
POTENTIAL “DUAL-USE” APPLICATIONS of DISCOVERIES IN BIOREGULATORS AND NEUROBIOLOGY: Kathryn Nixdorff, Ph.D. University of Darmstadt, Germany Elliott Kagan, M.D., Uniformed Services University of the Health Sciences |
|
4:20-4:30 |
Q&A/Discussion |
|
4:30-5:00 |
OPEN DISCUSSION |
